GlaxoSmithKline Pharmaceuticals research, manufacture and make available a broad range of medicines and vaccines that benefit people.(Source : Company Web-site)
Financial Results:
Glaxosmithkline Pharmaceuticals Ltd reported Revenues for Q3FY24 of ₹805.00 Crores up from ₹802.00 Crore year on year, a rise of 0.37%.
Total Expenses for Q3FY24 of ₹604.00 Crores up from ₹590.00 Crores year on year, a rise of 2.37%.
Consolidated Net Profit of ₹46.00 Crores down 72.12% from ₹165.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹2.70, down 72.19% from ₹9.71 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.